Dymond, A., Elks, C., Martin, P., Carlile, D., Mariani, G., Lovick, S., . . . So, K. (2017). Pharmacokinetics and pharmacogenetics of the MEK1/2 inhibitor, selumetinib, in Asian and Western healthy subjects: A pooled analysis. European Journal of Clinical Pharmacology, 73(6), 717-727.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
Dymond, Angela, et al. "Pharmacokinetics and Pharmacogenetics of the MEK1/2 Inhibitor, Selumetinib, in Asian and Western Healthy Subjects: A Pooled Analysis."
European Journal of Clinical Pharmacology 73, no. 6 (2017): 717-727.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
Dymond, Angela, et al. "Pharmacokinetics and Pharmacogenetics of the MEK1/2 Inhibitor, Selumetinib, in Asian and Western Healthy Subjects: A Pooled Analysis."
European Journal of Clinical Pharmacology, vol. 73, no. 6, 2017, pp. 717-727.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.